Journal Guide

The aim of Letters in Mathematical Physics is to attract the community's attention on important and original developments in the area of mathematical physics and contemporary theoretical physics. The journal publishes letters and longer research articles, occasionally also articles containing topical reviews. We are committed to both fast publication and careful refereeing. In addition, the journal offers important contributions to modern mathematics in fields which have a potential physical application, and important developments in theoretical physics which have potential mathematical impact.

Letters in Organic Chemistry publishes original letters, mini-reviews and guest edited issue in all areas of organic chemistry including synthesis, bioorganic, medicinal, natural products, organometallic, supramolecular, molecular recognition and physical organic chemistry. The emphasis is to publish quality papers rapidly by taking full advantage of latest technology for both submission and review of the manuscripts.

Letters in Spatial and Resource Sciences (LSRS) publishes high-quality, shorter papers on new theoretical or empirical results, models and methods in social sciences that contain a spatial dimension. It especially solicits manuscripts from regional science, regional and urban economics, geography, environmental and resource economics, demography, agricultural economics, GIS and spatial econometrics and planning. Examples of suitable contributions would be new formal derivations of theoretical or methodological results, new empirical findings, replications of empirical studies using new methodological approaches, short communications on new algorithms, evaluations of spatial econometric methods and meta-analyses. As a Letters Journal, it consists of concise communications (under 10 pages in length) that provide a means of rapid and efficient dissemination. It allows readers to determine their potential interest in a letter and to digest a large amount of information rapidly. Papers exceeding 10 pages in length will be considered for publication only if, in the opinion of an Editor-in-Chief, the additional length is justified by the nature of the question being studied and/or the quality of the analysis that is undertaken. LSRS also intends to contribute to the dissemination of theories and methodologies across disciplinary borders. The only letters journal in its field, LSRS is a valuable addition to the specialists literature in offering quick dissemination and easy accessibility of new results. Each article in LSRS is reviewed by two peer reviewers in a double blind fashion and classified according to the JEL classification system. Officially cited as: Lett Spat Resour Sci

Leukemia covers all aspects of the research and treatment of Leukemia and Allied Diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more.Impact Factor2010 Impact Factor: 8.966*Rank:4/65 Hematology10/184 Oncology*2010 Journal Citation Reports (Thomson Reuters, 2011)Abstracted/indexed inBIOBASE/Current Awareness in Biological SciencesBIOSISCambridge Scientific AbstractsCurrent Advances in Cell and Developmental BiologyCurrent Advances in Genetics and Molecular BiologyCurrent ContentsCurrent Contents/Life SciencesEMBASE/Excerpta MedicaMEDLINE/Index MedicusResearch AlertReference UpdateScience Citation IndexScience Citation Index ExpandedSUBISISSN and eISSNThe international standard serial number (ISSN) for Leukemia is 0887-6924, and the electronic international standard serial number (eISSN) is 1476-5551.

Leukemia & Lymphoma is an international journal that publishes full-length papers and reviews on clinical and therapeutic practice, epidemiological studies and outcomes analysis, laboratory diagnosis, pathology, cytology, ultrastructure, cytogenetics and cellular and molecular immunology of hematologic malignancies; the journal aims at a strong clinical-pathologic correlation. Letters and correspondence to the editors are also accepted on all topics, which are novel and provide new and interesting data for clinicians and postgraduate teaching. In addition, an update is provided on the basic issues and advances in molecular genetics as applied to this field. The journal will provide an important reference source for physicians and scientists who deal essentially with the clinical and laboratory diagnosis, clinical care and therapy of patients with these disorders.

Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Leukemia Research Reports is a new open access, international journal which will deliver timely information online to all health care professionals involved in basic and/or applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. Launched in late 2012, this is an online-only journal, specializing in rapid publication of peer-reviewed clinical research and short form papers, including brief communications, letters to the Editors, images,debate articles and most importantly case reports.The Editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies. Leukemia Research Reports' coverage encompasses the application of oncogenes, genomics (gene expression profiles, microRNAs), proteomics growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition articles are solicited on the rapidly growing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.Supported by an author fee of US$600/EUR 458/JPY 46,638 (exclusive of VAT/Sales Tax) the peer-reviewed content will be made available globally.Leukemia Research Reports is the sister journal of Leukemia Research.Abstracting and IndexingLeukemia Research Reports will initially be covered by Scopus and ScienceDirect.

Leviathan features a scholarly bounty of articles, notes, reviews, and creative writing of a critical, theoretical, cultural, or historical nature on the impressive body of work of American novelist and poet Herman Melville (1819-1891). Published under the aegis of The Melville Society one of the oldest single-author societies in the United States Leviathan includes a regular feature, Extracts, for sharing Melville Society transactions and programs as well as abstracts of papers delivered at its annual MLA and ALA panels. Leviathan also regularly publishes special issues, book reviews, interviews, and poems.